We are focused on providing information and technologies to researchers and clinicians to improve brain health. Join our global conversation and weekly blog posts!

Associated with Cerveau Technologies and Enigma Biomedical Group.

Cerveau Technologies, Inc. is a partnership between Enigma Biomedical Group, Inc. and Sinotau Pharmaceutical Group. Cerveau’s vision is to globally develop diagnostics and technology that positively impact patients with neurodegenerative disorders including Alzheimer’s disease.